30 min listen
Triple Antiviral Therapy for COVID-19, Remdesivir for Severe COVID-19, Convalescent Plasma, Hydroxychloroquine and Azithromycin in New York
Triple Antiviral Therapy for COVID-19, Remdesivir for Severe COVID-19, Convalescent Plasma, Hydroxychloroquine and Azithromycin in New York
ratings:
Length:
44 minutes
Released:
May 19, 2020
Format:
Podcast episode
Description
We're back with some of the latest updates on COVID-19! Are hydroxychloroquine or azithromycin associated with increased risk of mortality or cardiac arrest? Does triple combination antiviral therapy shorten time to a negative viral swab? Does remdesivir shorten time to clinical improvement? Should we be giving patients convalescent plasma? If you were the patient with severe COVID-19, which therapies would you want?Hydroxychloroquine and Azithromycin in New York CityTriple Combination Therapy for COVID-19 in Hong KongRemdesivir in adults with Severe COVID-19Treatment of 5 Patients with Convalescent PlasmaMusic from https://filmmusic.io"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)License: CC BY (http://creativecommons.org/licenses/by/4.0/)Dylan Sings Quarantine by Raffihttps://www.youtube.com/watch?v=xeEBcmkcJm8
Released:
May 19, 2020
Format:
Podcast episode
Titles in the series (57)
Upper GI Bleeding Guidelines, E-cigarette and Vaping Associated Lung Injury, Beta Blockers and HFpEF Exacerbations by Last Week in Medicine